CDC Study Finds Sharp Rise in Cannabis Hyperemesis Syndrome Prevalence from 2016 to 2022

A U.S. Centers for Disease Control and Prevention study reported a sharp rise from 2016 to 2022 in the prevalence of cannabis hyperemesis syndrome (CHS), a condition marked by recurrent nausea and vomiting associated with frequent cannabis use. The findings highlight the need to better understand cannabis-related health risks and strengthen clinical and public-health responses.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.